Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Tafenoquine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,268Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    60 Degrees Pharmaceuticals Expands Access to Arakoda
    60 Degrees Pharmaceuticals Expands Access to Arakoda

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230236/0/en/60-Degrees-Pharmaceuticals-Expands-Access-to-ARAKODA-with-GoodRx-Partnership.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    60 Degrees Pharma Announces Partnership With Runway Health
    60 Degrees Pharma Announces Partnership With Runway Health

    22 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/22/3223708/0/en/60-Degrees-Pharmaceuticals-Announces-Partnership-with-Runway-Health-to-Provide-International-Travelers-Direct-Access-to-ARAKODA-for-Malaria-Prevention.html

    GLOBENEWSWIRE
    22 Jan 2026
    Share Share
    60 Degrees Pharmaceuticals Announces Detection Of Babesia
    60 Degrees Pharmaceuticals Announces Detection Of Babesia

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210900/0/en/60-Degrees-Pharmaceuticals-Announces-Detection-of-Babesia-Infection-in-24-Percent-of-Patients-Presenting-with-Chronic-Fatigue-in-Peer-Reviewed-Sponsored-Study-at-NC-State.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    60 Degrees Pharmaceuticals Announces Expansion of Arakoda Sales
    60 Degrees Pharmaceuticals Announces Expansion of Arakoda Sales

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203873/0/en/60-Degrees-Pharmaceuticals-Announces-Expansion-of-ARAKODA-Sales-and-Marketing-in-2026.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    60 Degrees Pharmaceuticals Announces Clinical Site Now Open
    60 Degrees Pharmaceuticals Announces Clinical Site Now Open

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192770/0/en/60-Degrees-Pharmaceuticals-Announces-Clinical-Site-Now-Open-for-Patient-Enrollment-for-the-B-FREE-Chronic-Babesiosis-Study-at-Mount-Sinai-Icahn-School-of-Medicine.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    60 Degrees Drug Clears Babesia in Relapsing Babesiosis Study
    60 Degrees Drug Clears Babesia in Relapsing Babesiosis Study

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3166954/0/en/60-Degrees-Pharmaceuticals-Announces-No-Detection-of-Babesia-Infection-in-First-Patient-Following-Treatment-with-Tafenoquine-in-Relapsing-Babesiosis-Study.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.